The immunohistochemical detection of BiP in two small cohorts of luminal breast cancers disclosed a novel finding, the effect of endocrine treatment on BiP subcellular localization and confirmed that increased BiP expression is associated with metastasis and HER2 expression. Here, HSPA5 is linked to breast carcinoma.